IPHARMA continue to hold a series of webinars in order to provide information to the vast media audience on various aspects of clinical trials conduct.
Webinar "Findings during the inspections of Federal Service for Surveillance in Healthcare (Roszdravnadzor) in 2016"
The review of Roszdravnadzor findings in 2016 along with its classification, analysis, possible corrective and/or preventive actions.
Early phase studies is the most important stage of the drug development process.
The specifics of project management on start-up stage: what should we know and what should we do?
IPHARMA article "Possibilities of adaptive design implementation in clinical trial of netx-in-class drugs" has been published in The Bulletin of the Scientific Center for Expert Evaluation of Medicinal Products has published (4, 2016). The article investigates the possibility of streamlining the methodology of clinical studies of next-in-class drugs by implementing an adaptive design.
The development of pharmacologically similar agents and improved analogues of innovative drugs (next-in-class) is one of the target directions in evolution of Russian pharmaceutical industry under the “Pharma 2020” program.